UniProt ID | GATA3_HUMAN | |
---|---|---|
UniProt AC | P23771 | |
Protein Name | Trans-acting T-cell-specific transcription factor GATA-3 | |
Gene Name | GATA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 443 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcriptional activator which binds to the enhancer of the T-cell receptor alpha and delta genes. Binds to the consensus sequence 5'-AGATAG-3'. Required for the T-helper 2 (Th2) differentiation process following immune and inflammatory responses.. | |
Protein Sequence | MEVTADQPRWVSHHHPAVLNGQHPDTHHPGLSHSYMDAAQYPLPEEVDVLFNIDGQGNHVPPYYGNSVRATVQRYPPTHHGSQVCRPPLLHGSLPWLDGGKALGSHHTASPWNLSPFSKTSIHHGSPGPLSVYPPASSSSLSGGHASPHLFTFPPTPPKDVSPDPSLSTPGSAGSARQDEKECLKYQVPLPDSMKLESSHSRGSMTALGGASSSTHHPITTYPPYVPEYSSGLFPPSSLLGGSPTGFGCKSRPKARSSTGRECVNCGATSTPLWRRDGTGHYLCNACGLYHKMNGQNRPLIKPKRRLSAARRAGTSCANCQTTTTTLWRRNANGDPVCNACGLYYKLHNINRPLTMKKEGIQTRNRKMSSKSKKCKKVHDSLEDFPKNSSFNPAALSRHMSSLSHISPFSHSSHMLTTPTPMHPPSSLSFGPHHPSSMVTAMG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
71 | Phosphorylation | YGNSVRATVQRYPPT CCCCHHHHHCCCCCC | 13.45 | 23532336 | |
105 | Phosphorylation | DGGKALGSHHTASPW CCCCCCCCCCCCCCC | 16.97 | 23403867 | |
108 | Phosphorylation | KALGSHHTASPWNLS CCCCCCCCCCCCCCC | 24.33 | 23403867 | |
110 | Phosphorylation | LGSHHTASPWNLSPF CCCCCCCCCCCCCCC | 31.44 | 25849741 | |
115 | Phosphorylation | TASPWNLSPFSKTSI CCCCCCCCCCCCCCC | 22.23 | 22617229 | |
118 | Phosphorylation | PWNLSPFSKTSIHHG CCCCCCCCCCCCCCC | 38.11 | 25849741 | |
156 | Phosphorylation | HLFTFPPTPPKDVSP CCEECCCCCCCCCCC | 53.08 | - | |
162 | Phosphorylation | PTPPKDVSPDPSLST CCCCCCCCCCCCCCC | 33.45 | 23911959 | |
166 | Phosphorylation | KDVSPDPSLSTPGSA CCCCCCCCCCCCCCC | 42.19 | 30576142 | |
168 | Phosphorylation | VSPDPSLSTPGSAGS CCCCCCCCCCCCCCC | 36.57 | 25849741 | |
169 | Phosphorylation | SPDPSLSTPGSAGSA CCCCCCCCCCCCCCC | 36.64 | 25849741 | |
172 | Phosphorylation | PSLSTPGSAGSARQD CCCCCCCCCCCCCCC | 30.57 | 25849741 | |
186 | Phosphorylation | DEKECLKYQVPLPDS CHHHHHHCCCCCCCC | 11.20 | - | |
193 | Phosphorylation | YQVPLPDSMKLESSH CCCCCCCCCCCCCCC | 18.84 | 27251275 | |
195 | Ubiquitination | VPLPDSMKLESSHSR CCCCCCCCCCCCCCC | 53.72 | 29967540 | |
198 | Phosphorylation | PDSMKLESSHSRGSM CCCCCCCCCCCCCCC | 43.73 | 27251275 | |
199 | Phosphorylation | DSMKLESSHSRGSMT CCCCCCCCCCCCCCE | 18.99 | 24719451 | |
237 | Phosphorylation | SSGLFPPSSLLGGSP CCCCCCCHHHCCCCC | 33.58 | 27251275 | |
238 | Phosphorylation | SGLFPPSSLLGGSPT CCCCCCHHHCCCCCC | 33.13 | 27251275 | |
243 | Phosphorylation | PSSLLGGSPTGFGCK CHHHCCCCCCCCCCC | 19.93 | 28348404 | |
245 | Phosphorylation | SLLGGSPTGFGCKSR HHCCCCCCCCCCCCC | 47.00 | 28348404 | |
257 (in isoform 2) | Phosphorylation | - | 36.79 | 28348404 | |
258 (in isoform 2) | Phosphorylation | - | 29.36 | 24719451 | |
258 | Phosphorylation | SRPKARSSTGRECVN CCCCCCCCCCCCCCC | 29.36 | 24719451 | |
259 (in isoform 2) | Phosphorylation | - | 41.32 | 28348404 | |
261 | Dimethylation | KARSSTGRECVNCGA CCCCCCCCCCCCCCC | 33.94 | - | |
261 | Methylation | KARSSTGRECVNCGA CCCCCCCCCCCCCCC | 33.94 | - | |
271 | Phosphorylation | VNCGATSTPLWRRDG CCCCCCCCCCCCCCC | 20.32 | - | |
282 | Phosphorylation | RRDGTGHYLCNACGL CCCCCCCHHHHHHHC | 17.81 | 17360941 | |
290 | Phosphorylation | LCNACGLYHKMNGQN HHHHHHCHHHHCCCC | 5.67 | 17360941 | |
292 | Acetylation | NACGLYHKMNGQNRP HHHHCHHHHCCCCCC | 22.09 | 66281 | |
302 | Acetylation | GQNRPLIKPKRRLSA CCCCCCCCHHHHHHH | 52.77 | - | |
304 | Acetylation | NRPLIKPKRRLSAAR CCCCCCHHHHHHHHH | 45.19 | 66277 | |
308 | Phosphorylation | IKPKRRLSAARRAGT CCHHHHHHHHHHHCC | 20.33 | 16109788 | |
344 | Phosphorylation | VCNACGLYYKLHNIN CHHHHHHHHHHHCCC | 5.48 | - | |
346 | Acetylation | NACGLYYKLHNINRP HHHHHHHHHHCCCCC | 29.70 | 10970860 | |
369 | Phosphorylation | QTRNRKMSSKSKKCK HHHHHHCCCCCHHHH | 37.33 | - | |
371 | Acetylation | RNRKMSSKSKKCKKV HHHHCCCCCHHHHHH | 60.01 | 20167786 | |
373 | Acetylation | RKMSSKSKKCKKVHD HHCCCCCHHHHHHHH | 66.96 | 30588895 | |
374 | Acetylation | KMSSKSKKCKKVHDS HCCCCCHHHHHHHHC | 59.38 | 30588901 | |
376 | Acetylation | SSKSKKCKKVHDSLE CCCCHHHHHHHHCHH | 67.71 | 30588907 | |
377 | Ubiquitination | SKSKKCKKVHDSLED CCCHHHHHHHHCHHH | 55.03 | 29967540 | |
378 | Ubiquitination | KSKKCKKVHDSLEDF CCHHHHHHHHCHHHC | 3.56 | 29967540 | |
381 | Phosphorylation | KCKKVHDSLEDFPKN HHHHHHHCHHHCCCC | 20.84 | 25849741 | |
382 | Phosphorylation | CKKVHDSLEDFPKNS HHHHHHCHHHCCCCC | 10.23 | 24719451 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GATA3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GATA3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RBTN1_HUMAN | LMO1 | physical | 9819382 | |
RBTN2_HUMAN | LMO2 | physical | 9819382 | |
TAL1_HUMAN | TAL1 | physical | 9819382 | |
BMI1_HUMAN | BMI1 | physical | 17114435 | |
MDM2_HUMAN | MDM2 | physical | 15975924 | |
HDAC3_HUMAN | HDAC3 | physical | 17075044 | |
HDAC5_HUMAN | HDAC5 | physical | 17075044 | |
TBX21_HUMAN | TBX21 | physical | 17075044 | |
RARB_HUMAN | RARB | physical | 20211142 | |
HDAC4_HUMAN | HDAC4 | physical | 16922677 | |
MYB_HUMAN | MYB | physical | 22039304 | |
BRCA1_HUMAN | BRCA1 | physical | 22120723 | |
UBP21_HUMAN | USP21 | physical | 23395819 | |
PSA3_HUMAN | PSMA3 | physical | 25416956 | |
FBXW7_HUMAN | FBXW7 | physical | 24820417 | |
WEE1_HUMAN | WEE1 | genetic | 28319113 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
146255 | Hypoparathyroidism, sensorineural deafness, and renal disease (HDR) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-162, ANDMASS SPECTROMETRY. |